Enhancer regulatory elements for transcriptional regulation of human ltf gene expression and uses
By identifying and constructing transcriptional regulatory elements and vectors specific to the human LTF gene, the problem of low LTF expression efficiency in bovine mammary glands has been solved, achieving high-efficiency expression and supporting the development of mammary gland bioreactors and functional dairy products.
Patent Information
- Application Number
- CN202511006832.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-22
- Publication Date
- 2026-05-22
- Estimated Expiration
- 2045-07-22
AI Technical Summary
Existing technologies cannot explain the efficient expression of human lactoferrin (LTF) in bovine mammary glands. There is a lack of systematic discovery and validation of human-specific regulatory elements, and existing expression vectors rely on species-conserved elements, making it difficult to achieve high LTF expression at the human level.
Using enhancer regulatory elements and vectors that regulate the transcriptional expression of the human LTF gene, key regulatory sequences for extremely high expression of LTF in human milk were identified through multi-omics analysis such as ATAC-seq and ChIP-seq. The pGL4.17 and pcDNA3.1 vectors were constructed to achieve efficient cross-species expression.
It significantly activates reporter gene expression in bovine mammary epithelial cells, increasing expression efficiency to over 90% of the natural human level, reducing R&D cycle and cost, providing an efficient expression tool, and supporting the development of mammary bioreactors and functional dairy products.